Insider Transactions in Q2 2023 at Cara Therapeutics, Inc. (CARA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,723
-4.83%
|
$8,169
$3.51 P/Share
|
|
Jun 23
2023
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
2,993
-1.91%
|
$8,979
$3.51 P/Share
|
|
Jun 23
2023
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
2,483
-2.73%
|
$7,449
$3.51 P/Share
|
|
Jun 01
2023
|
Lisa Von Moltke |
BUY
Grant, award, or other acquisition
|
Direct |
32,362
+50.0%
|
-
|
|
Jun 01
2023
|
Martin Vogelbaum |
BUY
Grant, award, or other acquisition
|
Direct |
64,724
+37.1%
|
-
|
|
Jun 01
2023
|
Harrison M Bains Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,362
+36.04%
|
-
|
|
Jun 01
2023
|
Jeffrey L. Ives |
BUY
Grant, award, or other acquisition
|
Direct |
32,362
+40.35%
|
-
|
|
Jun 01
2023
|
Susan Ph.D. Shiff |
BUY
Grant, award, or other acquisition
|
Direct |
32,362
+38.62%
|
-
|
|
May 05
2023
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
3,869
-2.19%
|
$15,476
$4.4 P/Share
|
|
Apr 04
2023
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
2,733
-1.71%
|
$10,932
$4.91 P/Share
|
|
Apr 04
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,481
-4.21%
|
$9,924
$4.91 P/Share
|
|
Apr 04
2023
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
2,481
-2.65%
|
$9,924
$4.91 P/Share
|